Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7UR3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,470
Award facts
- Contract value 100% obligated
- $2,469.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,469.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors on December 19, 2025, with completion scheduled for January 13, 2026. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic categories. Tezspire is a biologic injection used for moderate-to-severe eosinophilic asthma treatment and represents part of the company's ongoing pharmaceutical supply mission supporting the Defense Health Agency and other government healthcare customers. The parent IDC vehicle enables flexible procurement of pharmaceutical products to support military healthcare operations globally, with DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts potentially involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F7UR3?
SPE2DR26F7UR3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F7UR3 worth?
The government has obligated $2,470 on SPE2DR26F7UR3.
Is contract SPE2DR26F7UR3 an order under another contract?
Yes. SPE2DR26F7UR3 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UR3 competed?
The extent of competition for SPE2DR26F7UR3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award